ARLAN BIOTECH

Transforming drug discovery using GenAI and synthetic data

ARLAN BIOTECH is a StartX company, having developed a functional Generative AI-powered SaaS platform that is actively generating precise nanobody sequences. We are successfully validating our technology through a third-party US-based CRO organization. In preliminary results, our AI outperformed Google DeepMind's AlphaProteo by 0.5% and Xaira Therapeutics by 11%, demonstrating the effectiveness and potential of our platform in revolutionizing nanobody discovery.

ARLAN BIOTECH is solving the problem of the lengthy, costly, and labor-intensive process of nanobody discovery in drug development. Traditionally, identifying effective nanobodies takes at least six months of experimental work, significantly slowing down pharmaceutical R&D. Our Generative AI-powered platform reduces this process to just minutes, allowing pharmaceutical companies to develop multiple nanobodies simultaneously, thus saving time, resources, and millions of dollars in a market worth $150–$200 billion.

Our solution is a Generative AI-powered SaaS platform that rapidly generates precise nanobody sequences against user-selected protein targets. By leveraging a proprietary AI model and synthetic data, we streamline the discovery process, reducing the time required from six months to just minutes. This technology eliminates the need for time-consuming lab experiments and enables the simultaneous development of multiple nanobodies for various targets. As a result, pharmaceutical companies can accelerate their R&D efforts, reduce costs, and bring therapies to market faster.

ARLAN BIOTECH operates on a SaaS (Software as a Service) business model. Pharmaceutical companies and biotech firms subscribe to our Generative AI-powered platform to generate precise nanobody sequences for their drug discovery programs. We offer a tiered subscription structure based on usage volume, target complexity, and the number of nanobodies being developed. This allows for flexible, scalable access to our platform, making it cost-effective for companies of various sizes. Additionally, we provide enterprise-level solutions for large pharmaceutical clients that include custom integrations

StartX, Silkway Google for Startups, MBRIF